Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

PHASE3TerminatedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

December 31, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

dutogliptin

400 mg

DRUG

placebo

Trial Locations (97)

Unknown

Phenomix Investigational Site 115, Montgomery

Phenomix Investigational Site 121, Tempe

Phenomix Investigational Site 137, Tempe

Phenomix Investigational Site 105, Anaheim

Phenomix Investigational Site 123, Chico

Phenomix Investigational Site 134, Escondido

Phenomix Investigational Site 103, Long Beach

Phenomix Investigational Site 106, Los Angeles

Phenomix Investigational Site 143, Coral Gables

Phenomix Investigational Site 142, Hialeah

Phenomix Investigational Site 119, Jacksonville

Phenomix Investigational Site 133, Kissimmee

Phenomix Investigational Site 141, Dunwoody

Phenomix Investigational Site 101, Honolulu

Phenomix Investigational Site 135, Chicago

Phenomix Investigational Site 124, Indianapolis

Phenomix Investigational Site 127, Indianapolis

Phenomix Investigational Site 136, Brockton

Phenomix Investigational Site 125, Kalamazoo

Phenomix Investigational Site 138, Biloxi

Phenomix Investigational Site 122, Las Vegas

Phenomix Investigational Site 140, Las Vegas

Phenomix Investigational Site 131, Brick

Phenomix Investigational Site 110, Trenton

Phenomix Investigational Site 116, Albuquerque

Phenomix Investigational Site 107, Winston-Salem

Phenomix Investigational Site 130, Cincinnati

Phenomix Investigational Site 118, Cuyahoga Falls

Phenomix Investigational Site 112, Greenville

Phenomix Investigational Site 102, Dallas

Phenomix Investigational Site 139, Dallas

Phenomix Investigational Site 126, El Paso

Phenomix Investigational Site 104, San Antonio

Phenomix Investigational Site 100, Kenosha

Phenomix Investigational Site 401, Buenos Aires

Phenomix Investigational Site 402, Buenos Aires

Phenomix Investigational Site 404, Buenos Aires

Phenomix Investigational Site 405, Buenos Aires

Phenomix Investigational Site 406, Buenos Aires

Phenomix Investigational Site 407, Buenos Aires

Phenomix Investigational Site 408, Buenos Aires

Phenomix Investigational Site 409, Buenos Aires

Phenomix Investigational Site 411, Buenos Aires

Phenomix Investigational Site 403, Corrientes

Phenomix Investigational Site 410, Mendoza

Phenomix Investigational Site 400, Rosario

Phenomix Investigational Site 502, Santiago

Phenomix Investigational Site 504, Santiago

Phenomix Investigational Site 505, Santiago

Phenomix Investigational Site 500, Temuco

Phenomix Investigational Site 501, Temuco

Phenomix Investigational Site 209, Chodov

Phenomix Investigational Site 205, Havířov-Město

Phenomix Investigational Site 204, Liberec

Phenomix Investigational Site 202, Olomouc

Phenomix Investigational Site 206, Ostrava-Kunčice

Phenomix Investigational Site 208, Prague

Phenomix Investigational Site 203, Prostějov

Phenomix Investigational Site 207, Uničov

Phenomix Investigational Site 201, Valašské Klobouky

Phenomix Investigational Site 703, Hyderabad

Phenomix Investigational Site 704, Visakhapatanam

Phenomix Investigational Site 709, Gopālapuram

Phenomix Investigational Site 707, Shāstrinagar

Phenomix Investigational Site 701, Bangalore

Phenomix Investigational Site 702, Bangalore

Phenomix Investigational Site 705, Trivandrum

Phenomix Investigational Site 706, Indore

Phenomix Investigational Site 711, Mumbai

Phenomix Investigational Site 700, Nashik

Phenomix Investigational Site 710, Navi Mumbai

Phenomix Investigational Site 708, Chennai

Phenomix Investigational Site 607, Arequipa

Phenomix Investigational Site 601, Ica

Phenomix Investigational Site 600, Lima

Phenomix Investigational Site 603, Lima

Phenomix Investigational Site 604, Lima

Phenomix Investigational Site 608, Lima

Phenomix Investigational Site 610, Lima

Phenomix Investigational Site 605, Lima Cercado

Phenomix Investigational Site 606, Piura

Phenomix Investigational Site 602, Trujillo

Phenomix Investigational Site 609, Wanchaq Cusco

Phenomix Investigational Site 300, Gdansk

Phenomix Investigational Site 301, Gdansk

Phenomix Investigational Site 303, Katowice

Phenomix Investigational Site 312, Katowice

Phenomix Investigational Site 309, Krakow

Phenomix Investigational Site 313, Krakow

Phenomix Investigational Site 308, Lublin

Phenomix Investigational Site 310, Poznan

Phenomix Investigational Site 306, Puławy

Phenomix Investigational Site 304, Szczecin

Phenomix Investigational Site 305, Warsaw

Phenomix Investigational Site 307, Warsaw

Phenomix Investigational Site 311, Warsaw

Phenomix Investigational Site 302, Wroclaw

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Phenomix

INDUSTRY